Clinical Trials · NCT01552343

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

Name: Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Desmopressin

Phase: Phase 3
Recruitment status: Completed
Sponsor: Ferring Pharmaceuticals
Enrollment: 56
Start date: Mar 2012
Locations: 10 sites, United States
Primary endpoint: The Pearson Correlation Coefficient Between Change From Baseline to Month 1 in Number of Nocturnal Voids and Change From Baseline to Month 1 in Nocturia Impact (NI) Diary Total Score

View Desmopressin compound reference